147 related articles for article (PubMed ID: 3928704)
1. Therapeutic manipulations in uremic bleeding.
Watson AJ; Whelton A
J Clin Pharmacol; 1985; 25(5):315-7. PubMed ID: 3928704
[No Abstract] [Full Text] [Related]
2. Evidence-based treatment recommendations for uremic bleeding.
Hedges SJ; Dehoney SB; Hooper JS; Amanzadeh J; Busti AJ
Nat Clin Pract Nephrol; 2007 Mar; 3(3):138-53. PubMed ID: 17322926
[TBL] [Abstract][Full Text] [Related]
3. Cryoprecipitate for uremic bleeding.
Davenport R
Clin Pharm; 1991 Jun; 10(6):429. PubMed ID: 1905991
[No Abstract] [Full Text] [Related]
4. [Treatment of uremic patients at high bleeding risk].
Kinugasa E; Makita T; Akizawa T; Koshikawa S
Nihon Rinsho; 1992 Jan; 50 Suppl():118-24. PubMed ID: 1578664
[No Abstract] [Full Text] [Related]
5. Bleeding in uremia--a clinical challenge.
Carvalho AC
N Engl J Med; 1983 Jan; 308(1):38-9. PubMed ID: 6401191
[No Abstract] [Full Text] [Related]
6. [Bleeding tendency in chronic kidney failure with hemodialysis].
Takahashi H; Shibata A
Nihon Rinsho; 1992 Jan; 50 Suppl():771-7. PubMed ID: 1578765
[No Abstract] [Full Text] [Related]
7. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.
Mannucci PM; Remuzzi G; Pusineri F; Lombardi R; Valsecchi C; Mecca G; Zimmerman TS
N Engl J Med; 1983 Jan; 308(1):8-12. PubMed ID: 6401193
[TBL] [Abstract][Full Text] [Related]
8. Variability in response to cryoprecipitate treatment for hemostatic defects in uremia.
Triulzi DJ; Blumberg N
Yale J Biol Med; 1990; 63(1):1-7. PubMed ID: 2113328
[TBL] [Abstract][Full Text] [Related]
9. Control of bleeding in severely uremic patients undergoing oral surgery.
Buckley DJ; Barrett AP; Koutts J; Stewart JH
Oral Surg Oral Med Oral Pathol; 1986 Jun; 61(6):546-9. PubMed ID: 2941716
[TBL] [Abstract][Full Text] [Related]
10. Bleeding disorders in uremia: pathophysiology and treatment.
Remuzzi G
Adv Nephrol Necker Hosp; 1989; 18():171-86. PubMed ID: 2493714
[TBL] [Abstract][Full Text] [Related]
11. Long-term therapy for uremic bleeding.
Sloand JA
Int J Artif Organs; 1996 Aug; 19(8):439-40. PubMed ID: 8841839
[No Abstract] [Full Text] [Related]
12. Management of uremic bleeding.
Couch P; Stumpf JL
Clin Pharm; 1990 Sep; 9(9):673-81. PubMed ID: 2171866
[TBL] [Abstract][Full Text] [Related]
13. [Hemostatic changes in extracorporeal surgery: pathogenesis and treatment].
Páramo JA; Rifón J; Rocha E
Sangre (Barc); 1993 Jun; 38(3):225-31. PubMed ID: 8211549
[No Abstract] [Full Text] [Related]
14. Bleeding in renal failure.
Remuzzi G
Lancet; 1988 May; 1(8596):1205-8. PubMed ID: 2897015
[No Abstract] [Full Text] [Related]
15. Low-dose intranasal desmopressin (DDAVP) for uremic bleeding.
Ozen S; Saatci U; Bakkaloglu A; Ozdemir S; Ozdemir O; Besbas N
Nephron; 1997; 75(1):119-20. PubMed ID: 9031290
[No Abstract] [Full Text] [Related]
16. Treatment of the bleeding tendency in uremia with cryoprecipitate.
Maierhoter W; Adams MB; Kleinman JG; Roth DA
N Engl J Med; 1981 Sep; 305(11):645. PubMed ID: 6790987
[No Abstract] [Full Text] [Related]
17. [Treatment of uremic patients with high bleeding risk].
Ogata H; Kinugasa E
Nihon Rinsho; 2004 Jun; 62 Suppl 6():70-4. PubMed ID: 15250271
[No Abstract] [Full Text] [Related]
18. Massive transfusion and nonsurgical hemostatic agents.
Perkins JG; Cap AP; Weiss BM; Reid TJ; Bolan CD
Crit Care Med; 2008 Jul; 36(7 Suppl):S325-39. PubMed ID: 18594260
[TBL] [Abstract][Full Text] [Related]
19. Cryoprecipitate. Patterns of use.
Pantanowitz L; Kruskall MS; Uhl L
Am J Clin Pathol; 2003 Jun; 119(6):874-81. PubMed ID: 12817436
[TBL] [Abstract][Full Text] [Related]
20. 1-Deamino-8-D-arginine vasopressin lowers protein C activity in uremics.
Aunsholt NA; Schmidt EB; Stoffersen E
Nephron; 1989; 53(1):6-8. PubMed ID: 2506477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
